Here, elevated levels of the pyroptosis-related indicators GSDMD, IL-1β, and IL-18 were confirmed in both clinical specimens from liver fibrosis patients and CCl4-induced liver fibrosis mouse models. This evidence concerns the gene GSDMD and Hepatic fibrosis.